MyFinsight
Home
Blog
About
Comprehensive loss
-$112,220K
(-113.92%↓ Y/Y)
Foreign currency
translation adjustment
$16K
(106.04%↑ Y/Y)
Net loss
-$111,456K
(-113.42%↓ Y/Y)
Unrealized (loss) gain on
investments
-$780K
(-2700.00%↓ Y/Y)
Loss before income
taxes
-$111,342K
(-113.29%↓ Y/Y)
Income tax provision
(benefit)
$114K
(470.00%↑ Y/Y)
Loss from operations
-$107,659K
(-95.17%↓ Y/Y)
Total other income
(expense), net
-$3,683K
(-224.43%↓ Y/Y)
Total revenue
$1,000K
Interest income
$6,603K
Other income
(expense), net
$16K
(-99.46%↓ Y/Y)
Total operating
expenses
$108,659K
(96.98%↑ Y/Y)
Interest expense on
royalty obligation
$6,837K
Interest expense on
convertible senior notes
$1,745K
Interest expense on
senior secured term...
$1,720K
Research and development
$62,913K
(46.22%↑ Y/Y)
Acquired in-process
research and development
$30,000K
General and
administrative
$15,746K
(29.75%↑ Y/Y)
Back
Back
Income Statement
Zenas BioPharma, Inc. (ZBIO)
Zenas BioPharma, Inc. (ZBIO)
source: myfinsight.com